Matches in Nanopublications for { ?s ?p "[If BLP ligand-receptor systems are to be targeted therapeutically in NSCLC, it will be necessary to inhibit both NMB and GRP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_assertion description "[If BLP ligand-receptor systems are to be targeted therapeutically in NSCLC, it will be necessary to inhibit both NMB and GRP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_provenance.
- NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_assertion description "[If BLP ligand-receptor systems are to be targeted therapeutically in NSCLC, it will be necessary to inhibit both NMB and GRP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953241.RA_Ry_zZ7bhoF_Ss8vC66UqaWwGoUOCYJThVcW5nGNN0s130_provenance.
- NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_assertion description "[If BLP ligand-receptor systems are to be targeted therapeutically in NSCLC, it will be necessary to inhibit both NMB and GRP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_provenance.